$CPAC

Is Cementos Pacasmayo (CPAC) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Original reporting
Zacks Commentary · Zacks Equity Research
Published Nov 7, 2025, 2:40 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 8, 2025, 1:01 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Is Cementos Pacasmayo (CPAC) Stock Undervalued Right Now? — source image
Decision brief

The 30-second read

$CPACBullishMed
01

Why it matters

The article's emphasis on valuation suggests a possible undervaluation, which could attract value investors.

02

Market read

The news is relevant for investors focusing on Latin American construction materials stocks, especially those employing value strategies.

03

What to watch

Potential macroeconomic risks, currency fluctuations, and company-specific operational challenges that could impact future performance.

Relevance 6/10Timing: long-term

Background

Cementos Pacasmayo operates in the construction materials industry in Peru, with recent focus on valuation and earnings estimates.

Company-level read

Ticker impact

$CPACBullishMedium confidence
Context

The article discusses Cementos Pacasmayo's valuation status, which is relevant for investors interested in the cement industry and Peruvian market.

Expected impact

Moderate upward price movement over the next 3-6 months if valuation gap narrows.

Evidence & confidence

The article emphasizes valuation metrics and earnings estimates, which are favorable for long-term valuation-based strategies. Lack of technical signals and current price data limit short-term trading confidence.

Market effects

Potential positive impact on the construction materials sector in Peru and Latin America.

Limited regional impact due to focus on a specific company and market.

Low; the news is region-specific and pertains to a local market.

Counterpoint

The valuation may already reflect market expectations, and the stock could be overvalued if earnings estimates are overly optimistic.

Key entities

  • Cementos Pacasmayo

    A leading cement producer in Peru.

Related articles

$RYTMMed

Rhythm Pharmaceuticals launches IMCIVREE in Japan for obesity

Rhythm Pharmaceuticals (RYTM) launched IMCIVREE in Japan for treating acquired hypothalamic obesity. The drug, approved by Japan's Ministry of Health, showed an 18.8% placebo-adjusted BMI reduction in trials. It's the first approved therapy for this condition in Japan, with 5,000-8,000 potential patients. RYTM also markets the drug in the U.S. and Europe for similar indications.

$CIENMed

Space Norway selects Ciena to upgrade its legacy Svalbard system and power new Arctic Way subsea cable

Space Norway has chosen Ciena (NYSE: CIEN) to upgrade its Svalbard subsea cable systems and deploy new technology on the Arctic Way system, set to launch in 2028. The project aims to extend the operational life of existing infrastructure and enhance connectivity in the Arctic. Ciena will provide design, deployment, and optical technology, including the Ciena 6500 Optical Platform and Navigator Network Control Suite, to improve network resilience and capacity.